Canada Markets closed

CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALL

OAKVILLE, ON, Oct. 26, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q3 2022 financial results on Thursday, November 10, 2022 after market close. The company will hold a conference call on Friday, November 11, 2022 at 8:30am ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

DATE:                                     

Friday, November 11, 2022

TIME:                                     

8:30 a.m. EDT

DIAL-IN NUMBER:               

(416) 764-8650 or (888) 664-6383

CONFERENCE ID:                 

59484713

REPLAY DIAL-IN:                 

(888) 390-0541 (playback 484713#)
Expires November 18, 2022

WEBCAST:                           

https://app.webinar.net/ApnV68m4x1k

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/October2022/26/c6966.html